|
|
|
|
EFFECTIVENESS AND TOLERABILITY OF DTG+3TC
IN CLINICAL PRACTICE: EVIDENCE IN PLHIV FROM REAL-WORLD DATA
|
|
|
Lee A. Evitt,1 Rahul Kumar,2 Rahul Dinesh Kamath,2 Diwakar Jha,2 Daniel Parks,3 Jean van Wyk,1 Annemiek de Ruiter1
1ViiV Healthcare, London, UK; 2GlaxoSmithKline Knowledge Centre, Gurgaon, India; 3GlaxoSmithKline, Upper Providence, PA, USA
|
|
|
|
|
|
|